Kristina Benedikte Vangsted Døssing

Medicine & Life Sciences

1. MicroRNAs 100%
2. Neuroendocrine Tumors 94%
3. Somatostatin 82%
4. Up-Regulation 74%
5. Macrophages 55%
6. Urokinase Plasminogen Activator Receptors 55%
7. Neuroendocrine Cells 50%
8. Polyadenylation 50%
9. Ghrelin 47%
10. RNA Sequence Analysis 44%
11. Genes 42%
12. Tumor Suppressor Genes 39%
13. DNA Methylation 39%
14. Glioblastoma 39%
15. Cardiomyopathies 38%
16. Lipoproteins 37%
17. Positron-Emission Tomography 36%
18. Interferons 36%
19. Evaluation Studies 35%
20. Mesenchymal Stem Cells 35%
21. Growth 33%
22. Atherosclerosis 31%
23. Datasets 31%
24. Carcinoid Tumor 30%
25. Monocytes 28%
26. Down-Regulation 27%
27. Cytokines 24%
28. Neoplasm Metastasis 24%
29. Coronary Vessels 20%
30. Stem Cells 18%
31. Atherosclerotic Plaques 15%
32. Annulus Fibrosus 14%
33. Cell Line 13%
34. Nucleus Pulposus 12%
35. Mononuclear Phagocyte System 12%
36. Neoplasms 12%
37. Intervertebral Disc Degeneration 12%
38. CD4-CD8 Ratio 12%
39. Gene Expression 11%
40. Intervertebral Disc 11%
41. Injections 11%
42. Dopamine 11%
43. Carcinogenesis 10%
44. Calcium 10%
45. In Situ Hybridization 10%
46. Stromal Cells 9%
47. Messenger RNA 9%
48. Immunohistochemistry 9%
49. Ligation 8%
50. Extracellular Matrix 8%